Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.

Sionna Therapeutics SION) stock rises as the clinical-stage biopharma focused on cystic fibrosis therapies makes its public ...

The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or ...

Sionna Therapeutics (SION), which is developing drugs to treat cystic fibrosis, has filed to raise $100M through an initial public offering. While Sionna (SION) didn't disclose terms in its SEC filing ...

Sionna Therapeutics hopes to raise $150 million and secure a market capitalization of about $692 million in an initial public ...